Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
Cogentix Medical, Molecular Templates, Celldex Therapeutics, Cerus and Kura Oncology top the NASDAQ biotech stock list.
Novavax, Agenus, Sierra Oncology, Durect and Cogentix top the NASDAQ biotech stock list.
MEI Pharma, AVEO Pharmaceuticals, Albireo Pharma, Athersys and CASI Pharmaceuticals top the list.
AVEO, leads the list of last week’s life science gainers on the NASDAQ, followed by BioDelivery Sciences, Dynavax, Catalyst and Ekso Bionics.
Think personalized medicine and a few things come to mind: namely, genetically tailored drugs and genome-based therapies. Medical devices aren’t most people’s first thought—but that may be changing, and fast.
“White hat” hackers can test cyber vulnerabilities of connected medical devices without fear of legal repercussion.
If you couldn’t attend the London event, never fear: today, we’re counting down the top three investor takeaways. It’s almost as good as being there.
On October 27, 2016, biotech experts and industry professionals will converge on London to discuss the sector’s outlook.
By Vivien Diniz
Tech mogul Sean Parker announced that he would be donating a significant $250 million to support immunotherapy research
Nasdaq is making moves to delist KaloBios in the wake of former CEO Martin Shkreli’s arrest. Meanwhile, Turing Pharmaceuticals, of which Shkreli was a co-founder, is laying off employees this month.